Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators | Journal of the American Chemical Society
![Integrative scheme of Kappa Opioid Receptors (KOR) control on direct... | Download Scientific Diagram Integrative scheme of Kappa Opioid Receptors (KOR) control on direct... | Download Scientific Diagram](https://www.researchgate.net/publication/339334172/figure/fig1/AS:859923730677762@1582033202877/Integrative-scheme-of-Kappa-Opioid-Receptors-KOR-control-on-direct-D1R-and-indirect_Q640.jpg)
Integrative scheme of Kappa Opioid Receptors (KOR) control on direct... | Download Scientific Diagram
![Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder | SpringerLink Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F164_2021_499/MediaObjects/500126_1_En_499_Fig1_HTML.png)
Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder | SpringerLink
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
Obsessive-Compulsive Disorder Interactome Profile Analysis: A Perspective From Molecular Mechanism - Basic and Clinical Neuroscience
![Antioxidants | Free Full-Text | An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders Antioxidants | Free Full-Text | An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders](https://www.mdpi.com/antioxidants/antioxidants-11-00353/article_deploy/html/images/antioxidants-11-00353-g001.png)
Antioxidants | Free Full-Text | An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders
![Brain Sciences | Free Full-Text | Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature Brain Sciences | Free Full-Text | Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature](https://www.mdpi.com/brainsci/brainsci-11-00856/article_deploy/html/images/brainsci-11-00856-g002.png)
Brain Sciences | Free Full-Text | Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
![N‐acetylcysteine as a new prominent approach for treating psychiatric disorders - Smaga - 2021 - British Journal of Pharmacology - Wiley Online Library N‐acetylcysteine as a new prominent approach for treating psychiatric disorders - Smaga - 2021 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/b2920d54-7f59-4eb7-af54-a9b6e8f7f23a/bph15456-toc-0001-m.jpg)
N‐acetylcysteine as a new prominent approach for treating psychiatric disorders - Smaga - 2021 - British Journal of Pharmacology - Wiley Online Library
![Frontiers | Rapid-Onset Anti-Stress Effects of a Kappa-Opioid Receptor Antagonist, LY2795050, Against Immobility in an Open Space Swim Paradigm in Male and Female Mice Frontiers | Rapid-Onset Anti-Stress Effects of a Kappa-Opioid Receptor Antagonist, LY2795050, Against Immobility in an Open Space Swim Paradigm in Male and Female Mice](https://www.frontiersin.org/files/MyHome%20Article%20Library/775317/775317_Thumb_400.jpg)
Frontiers | Rapid-Onset Anti-Stress Effects of a Kappa-Opioid Receptor Antagonist, LY2795050, Against Immobility in an Open Space Swim Paradigm in Male and Female Mice
Obsessive-Compulsive Disorder Interactome Profile Analysis: A Perspective From Molecular Mechanism - Basic and Clinical Neuroscience
![κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition | Neuropsychopharmacology κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition | Neuropsychopharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnpp.2017.133/MediaObjects/41386_2018_Article_BFnpp2017133_Fig4_HTML.jpg)
κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition | Neuropsychopharmacology
![Protein-Protein Interaction Analysis of Common Top Genes in Obsessive-Compulsive Disorder (OCD) and Schizophrenia: Towards New Drug Approach Obsessive-Compulsive disorder (OCD) and Schizophrenia Comorbidity Gene Analysis | Iranian Journal of ... Protein-Protein Interaction Analysis of Common Top Genes in Obsessive-Compulsive Disorder (OCD) and Schizophrenia: Towards New Drug Approach Obsessive-Compulsive disorder (OCD) and Schizophrenia Comorbidity Gene Analysis | Iranian Journal of ...](https://services.brieflands.com/cdn/serve//315db/9dae74dc3b0896102a49ae3ffcc0886a74e0b79d/ijpr-17-173-g006.jpg)
Protein-Protein Interaction Analysis of Common Top Genes in Obsessive-Compulsive Disorder (OCD) and Schizophrenia: Towards New Drug Approach Obsessive-Compulsive disorder (OCD) and Schizophrenia Comorbidity Gene Analysis | Iranian Journal of ...
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
![An Adenosine A2A Receptor Antagonist Improves Multiple Symptoms of Repeated Quinpirole-Induced Psychosis | eNeuro An Adenosine A2A Receptor Antagonist Improves Multiple Symptoms of Repeated Quinpirole-Induced Psychosis | eNeuro](https://www.eneuro.org/content/eneuro/6/1/ENEURO.0366-18.2019/F9.large.jpg)
An Adenosine A2A Receptor Antagonist Improves Multiple Symptoms of Repeated Quinpirole-Induced Psychosis | eNeuro
![κ Opioid Receptor-Dynorphin Signaling in the Central Amygdala Regulates Conditioned Threat Discrimination and Anxiety | eNeuro κ Opioid Receptor-Dynorphin Signaling in the Central Amygdala Regulates Conditioned Threat Discrimination and Anxiety | eNeuro](https://www.eneuro.org/content/eneuro/8/1/ENEURO.0370-20.2020/F1.large.jpg)